| Item | Content |
|---|---|
| Rating | Cautiously Bullish |
| Target Price | HKD 5.2–6.7 (base-case fair value range, 12–18 months) |
| Current price (closing price 2026-10-30, frozen anchor) | HKD 4.035 — Note: trading has been suspended by SFC directive since 2026-10-13; the last actual trading day was 2026-10-12, and this price is a carry-forward label of the pre-suspension close |
| Total market cap | Approx. HKD 5.96 billion (1.4776 billion shares outstanding) |
| Margin of safety | +28.9% (current price vs. lower bound of base range at HKD 5.2) |
| Probability-weighted fair value | Approx. HKD 5.63 (~+39% vs. current price) |
| Time horizon | 12–18 months |
Net cash accounts for nearly 70% of market cap, with binary suspension risk dominating the odds; cautiously bullish, with resumption as the guiding framework. ChaPanda's book net cash is approx. RMB 3.5 billion (approx. HKD 4.1 billion, HKD 2.79 per share, ~69% of market cap); EV excluding operations is only approx. RMB 1.56 billion, equivalent to ~2.4x FY2025 recurring net profit (RMB 658 million); PE(TTM) of 6.35x and TTM dividend yield of ~9.6% are both at all-time lows since listing. However, on 2026-10-13, the SFC suspended trading under Section 8(1) of the Securities and Futures (Listing on Stock Exchanges) Rules, investigating whether the IPO demand was artificially manipulated to create a false impression of demand — the right to resume trading rests with regulators; no historical case of this type resumed trading within 12 months, and a tail risk exists of a Hontex-style share buyback and delisting or even deregistration. Meanwhile, leading indicators of the franchise system (three consecutive declines in contract liabilities, active members -36% over six months, store closure rate ~11%) indicate the operating base is genuinely weakening. Our judgment: this is an event-driven deep value play with "positive expected value of the post-resumption distribution," but it is untradeable during the suspension and unsuitable for general position building until the resumption path becomes clear.
Variables most likely to change over the next 12–18 months: First, the company-side response to the SFC investigation — management stated via media that it intends to deliberate establishing an independent investigation committee at an early-November board meeting (as of this report, only media reports, not yet a company announcement); if the conclusion confines the issue to the external placing recipient group (Sun Ran and 8 related companies, asset restriction cap of HKD 4.379 billion), substantive resumption negotiations would begin; second, forced convergence of the suspension's trajectory — the 18-month deadline under Listing Rule 6.01A (2028-04-13) means a definitive outcome (resumption, settlement, or delisting proceedings) must occur within 18 months; third, the 2026 annual report (expected 2027-03) validating the franchise system and the coffee/overseas second growth curves.
Primary share price driver: Regulatory conclusions and resumption path > net cash accessibility (timely dividend payments are the most direct verifiable signal) > franchise system fundamentals. These correspond respectively to the direction of valuation discount convergence, the quality of the asset floor, and the direction of the profit denominator.
Verifiable expectation gap: Back-solving from the current price implies the market assumes operations are worth only ~28% of a zero-growth perpetuity FCFE — equivalent to recurring profit permanently falling from the realistic RMB 650–700 million to ~RMB 240 million. The premise for this expectation gap to hold is that "the RMB 3.5 billion cash is real and ultimately accessible" — precisely the question the SFC investigation seeks to answer; if company-level involvement is confirmed, the current discount is instead justified. The falsification checkpoints are clear: whether the 2026-11-30 interim dividend (RMB 221.6 million) is paid in full, whether a resumption guidance letter is received before mid-January 2027, and the 2026 annual report's distributable reserves and proposed final dividend.
Validation catalysts and falsification conditions: Positive — independent investigation committee announcement, resumption guidance letter, on-schedule dividend payments, controlling shareholder increasing stake after resumption; Negative — listed company being named as an investigation subject or accounts restricted, investigation scope expanding to fund repatriation, dividend suspension, 2026 annual report confirming accelerated store closures (>1,000 for the full year) and gross margin falling below 29%.
At HKD 4.035, market cap is HKD 5.96 billion, of which the cash layer is approx. HKD 4.13 billion (HKD 2.79 per share, 69%); EV of operations excluding cash is approx. RMB 1.56 billion, only 2.37x FY2025 recurring net profit of RMB 658 million and 1.87x the company-defined adjusted net profit of RMB 833 million. Two adjustments must be stated simultaneously: first, the RMB 175 million FVOCI position is listed equity (cumulative fair value losses of RMB 494 million recognized, still widening), not a stable cash equivalent; excluding it, the cash floor is approx. HKD 2.66 per share; second, the SFC announcement explicitly stated that parties involved "may in future be ordered to compensate affected investors through restitution proceedings"; if we benchmark against the Hontex precedent and buy back public shares at the suspension price (~15.3% × 1.4776 billion shares × 4.035 ≈ HKD 910 million), net cash falls to approx. HKD 2.18 per share. It must also be declared: the frozen anchor is in fact the price of the last trading day (2026-10-12) before the allegations were made public — the reading that "the market has already priced in event risk" does not hold on timing; more accurately, the suspension froze price discovery before the negative news became public, and the direction of the first-day flush on resumption is open in both directions.
The interpretation must present both sides in parallel: weakening evidence (contract liabilities -70% over 2.5 years, members -36%, per-store goods sales ~-5.5% [Guotai Haitong estimate], 933 stores closed annually) versus offsetting evidence (policy-driven item migration, high share of store transfers, franchisee count still growing). Combined judgment: the base where ~95% of revenue comes from selling goods and equipment to franchisees is under pressure, but evidence of "system collapse" is insufficient. This report forecasts FY2027 revenue of approx. -2% to +1% (RMB 5.3–5.6 billion); if the 2026 annual report confirms >1,000 store closures for the full year and gross margin falling below 29%, downside risk rises significantly.
Empirical base rates for historical cases of the same type (fraud/misstatement allegations under Section 8(1)) do not support rapid resumption: Hontex International was suspended in 2010-03, reached a settlement after ~26 months (delisted after buying back over HKD 1 billion of public shares at the suspension price of HKD 2.06), and was deregistered in 2013-09; Hanergy Thin Film was suspended in 2015 and delisted after ~5 years; the co-implicated Bluetech Healthcare (since 2026-09-10) and Silver Base International (since 2026-09-25) remain suspended with no substantive progress. The key differentiating facts must be emphasized: ChaPanda has a genuinely profitable business and RMB 2.96 billion in cash; the unutilized IPO proceeds of HKD 707 million remain in interest-bearing accounts at licensed banks (disclosed in the interim report); company accounts have not been frozen; and the dividend channel is operating normally during the suspension — this is fundamentally different from historically suspended shell companies/financial fraud entities, and is the core reason the bear-case probability is no higher than 30%. The winning move for resumption lies in whether the investigation's conclusion confines the issue to the external placing recipient group.
Governance fact list: controlling shareholders Wang Xiaokun/Liu Weihong (couple) hold a combined 82.73%, public float only ~15.3% (waiver arrangement); dividend policy reversed twice within a year (FY2023 dividend approved then withdrawn, replaced 4 months later with a larger special dividend); supervisory board abolished; the sole Pre-IPO institutional shareholder Orchid Asia (Tower Quality) exited fully between May–July 2025. But fairness in pricing requires noting: the stock has fallen from the HKD 17.5 issue price to 4.035 (-77%), already pricing in substantial governance doubts; it was removed from the Hang Seng Composite Index and Stock Connect on 2026-10-23, so passive selling pressure was front-loaded during the suspension rather than hanging over the resumption; the controlling shareholders' 82.73% stake deeply aligns their interests with share price repair, and the 10% incentive plan can also be read as management's motivation to tie themselves to post-resumption performance. The real governance risk is the weak bargaining power of minority shareholders after resumption — if a low-price privatization offer emerges, public shareholders lack leverage (H shares have no mandatory squeeze-out; refusers become illiquid shareholders).
The gross margin attribution must be decomposed: ~1.4 percentage points is coffee-related benefit-sharing, while the remaining ~1.2 percentage points is more likely a structural effect from the surge in low-margin equipment revenue — it cannot all be booked as "strategic benefit-sharing." The conversion chain currently reads negative — while coffee cup volume exceeds 10%, goods (materials) revenue fell -2.3% YoY, indicating equipment deployment has not yet produced observable incremental materials sales; the 18-month installments mean part of H1 revenue growth of +6.2% was financed by credit expansion to franchisees, carrying dual attributes of "real progress" and "credit risk" against the backdrop of per-store goods sales at -5.5%. Overseas is cleaner growth: the Korean entity is a 55%-owned consolidated subsidiary, "profitable overall" is management's results-briefing framing (even if true, there is a 45% minority leakage), and the unit economics and replicability await validation via the annual report's segment data.
| Metric (RMB) | FY2023 | FY2024 | FY2025 | 2026H1 (latest period) |
|---|---|---|---|---|
| Revenue (RMB 100mn) | 57.04 | 49.18 | 53.95 | 26.55 |
| YoY | — | -13.8% | +9.7% | +6.2% |
| Net profit attributable to owners (RMB 100mn) | 11.39 | 4.72 | 8.05 | 3.36 |
| YoY | — | -58.5% | +70.5% | +3.2% |
| Adjusted net profit (company definition, RMB 100mn) | 12.58 | 6.45 | 8.33 | Not separately disclosed |
| Recurring net profit (our estimate, RMB 100mn) | — | 3.12 | 6.58 | 3.14 |
| Gross margin | 34.4% | 31.2% | 32.5% | 30.0% |
| Net margin attributable to owners | 20.0% | 9.6% | 14.9% | 12.7% |
| Operating cash flow (RMB 100mn) | 13.88 | 3.44 | 6.80 | 1.92 |
| Free cash flow (RMB 100mn) | 13.03 | 2.79 | 6.56 | 1.74 |
| Cash and cash equivalents (period-end, RMB 100mn) | — | 35.60 | 30.71 | 29.64 |
| Interest-bearing debt (bank borrowings, RMB 100mn) | 0 | 0 | 0 | 0 |
| Liabilities/total assets | 72.6%* | 28.4% | 16.8% | 15.9% |
| Net debt/EBITDA | Net cash | Net cash | Net cash | Net cash |
*FY2023 includes pre-listing redeemable share liabilities; not comparable. At 2026H1 end, the company also held FVTPL wealth management products of RMB 432 million and FVOCI equity investments of RMB 175 million; cash-like assets totaled RMB 3.571 billion; total lease liabilities were RMB 68 million. The company-defined "adjusted net profit" only adds back share-based payments (RMB 12 million added back in FY2025) and does not exclude government grants (RMB 58 million) or wealth management/interest income — a loose definition; our estimated "recurring net profit" excludes government grants, wealth management fair value gains and bank interest, and adds back FX losses (FY2025: 8.05−0.58−0.69−0.35+0.15=6.58 RMB 100mn; one-off items were 18.2% of attributable profit).
Reasons for metric changes (summary of YoY ≥ ±20%, all per company disclosures): FY2024 revenue -13.8% — management attributed it to "changes in consumer habits due to the external environment……and shifts in the competitive landscape," offset by increased support and sales incentives for franchisees; FY2024 distribution and selling expenses +201.6% — "expanding brand presence through digital marketing, IP marketing, cross-industry collaborations, celebrity endorsements and anniversary campaigns"; FY2024 attributable profit -58.5% was due to revenue decline plus gross margin -3.2pp (benefit-sharing and materials subsidies for franchisees); FY2025 attributable profit +70.5% — "strengthened cost control and improved warehousing and logistics management" drove gross margin +1.3pp and lower expenses; 2026H1 equipment revenue +450% — freshly-made coffee equipment store deployment, corresponding to trade receivables +325% (18-month installment credit); 2026H1 operating cash flow -31.6% — coffee equipment receivables tying up working capital (company attribution: "increase in accounts receivable"); FY2025 dividends paid of RMB 1.093 billion (vs. RMB 13 million prior year) — including special dividend of RMB 532 million and final/interim dividends.
2026H1 revenue RMB 2.655 billion (+6.2%), net profit attributable to owners RMB 336 million (+3.2%), recurring net profit estimated in this report at RMB 314 million, gross margin 30.0% (-2.6pp), operating cash flow RMB 192 million (-31.6%). Structural breakdown: growth came almost entirely from coffee equipment deployment (equipment revenue increment of RMB 219 million ≈ 140%+ of the total revenue increment of RMB 155 million, i.e., ex-equipment organic revenue was negative — goods -2.3%, franchise fees -19.5%); of the gross margin decline, ~1.4pp was coffee benefit-sharing and ~1.2pp was the equipment revenue mix effect; period-end store count 8,863 (+4.7%), of which 72 overseas. Compared with the latest pre-suspension sell-side expectations: CICC (2026-08-30) FY2026E net profit RMB 836 million, Guotai Junan (2026-08-29) RMB 845 million — implying an H2 requirement of RMB 500–510 million, higher than FY2025H2's RMB 479 million, meaning sell-side expectations look optimistic given the H1 growth slope of only +3.2%; this report's FY2026E attributable profit of RMB 730–790 million (implying H2 of -5% to -18%) is below both. There have been no sell-side updates since the suspension, and no effective market pricing reaction to these interim results is observable (the stock continued weakening after disclosure until suspension).
Business model in brief: An asset-light franchised supply chain model—headquarters does no retail; in essence it is "a wholesaler of ingredients/equipment/packaging serving 6,038 franchisees + a brand licensor": 94.9% of revenue comes from selling goods and equipment to franchisees, royalties and franchise fees account for only 3.6%, and its 13 directly operated stores serve merely as brand showcases. Revenue is predominantly recognized upfront (franchise fee amortization recognized over time accounts for only 3.8%); no subscription attributes. Bargaining power vis-à-vis upstream suppliers is strong (own tea factory with 5,000-ton annual capacity, Senmian packaging plant, 26 warehousing and distribution centers, next-day delivery to 93.7% of stores), while bargaining power over downstream franchisees has weakened amid the price war—gross margin declined twice within three years due to "concessions to franchisees" (FY2024 -3.2pp, 2026H1 -2.6pp), with no pricing power at the end-consumer level.
Cash content test of earnings: OCF/net profit attributable to parent = 1.21 (FY2023) →0.72 (FY2024) →0.83 (FY2025) →0.56 (2026H1); FCF/net profit attributable = 1.14→0.59→0.82→0.52. A deteriorating trend, with 2026H1 falling below the 0.6 warning line, mainly due to working capital absorbed by credit expansion from 18-month installment receivables on coffee equipment (each incremental RMB 1 of revenue absorbs roughly RMB 0.6 of working capital)—the conversion of book profit into freely disposable cash is deteriorating, and receivables aging migration must be verified in the 2026 annual report. Recurrence test: of FY2025's net profit attributable of RMB 805 million, approximately RMB 147 million came from government grants, wealth-management returns, and interest (18.2%), leaving core operating profit of RMB 658 million; cross-checking the company's own "adjusted" figure—it only adds back RMB 12 million of SBC while retaining all grants and wealth-management returns, a loose definition (relatively harmless, but investors should not treat the full RMB 833 million as operating profit).
Return on capital: FY2025 operating ROIC of approximately 20% (NOPAT RMB 821 million / invested capital approx. RMB 4.1 billion), significantly above WACC—but approximately RMB 350 million of idle cash in the denominator depresses the apparent figure; the true cash return on operating assets is higher. Under the asset-light model, this is a "cash cow" type return structure.
CapEx quality: CapEx/depreciation FY2023–FY2025 = 1.27→0.72→0.24, with PP&E book value shrinking continuously (2.36→2.03 hundred million RMB); the company does not disclose a maintenance/growth split—but under the franchise model, capacity investment is inherently very light; low capital intensity is an inherent virtue of this business model, and there is no capital black-hole problem.
Moat and quality red flags: The moat derives from the supply chain network (capability of high-frequency nationwide delivery of fresh milk, fresh fruit, and short-shelf-life items) and franchisee relationships, not brand premium. Three red flags: after listing, the company ceased disclosing quantitative KPIs such as per-store GMV/same-store sales/payback period (retaining only qualitative statements like "per-store sales performance remains steady," a regression in verifiability); active members have declined continuously, with a sharp 36% drop in 2026H1; closure rate remains elevated at around 11% while store expansion decelerates.
Consistency between words and deeds: partially delivered, selective disclosure. Three examples of commitments vs. delivery: ① The FY2024 annual report pledged to "continue expanding the store network and strengthen overseas expansion"—actual mainland stores +2.7%, overseas 14→38 stores; delivered, with overseas exceeding expectations; ② When cancelling the FY2023 dividend in July 2024, the company pledged that "total adjusted payout would be no less than the original plan"—in December 2024, it paid a special dividend of RMB 532 million instead (exceeding the original plan); delivered but with a twisting path; ③ The 2026 interim report stated "per-store sales performance remains steady"—no quantitative disclosure to verify, while active members fell 36% and franchise fee revenue fell 19.5% over the same period; the statement is in tension with available data. Overall verdict: financial commitments largely delivered, but disclosure definitions are selectively favorable, and key operating metrics (per-store) have degraded to qualitative descriptions.
Shareholder friendliness: high dividends coexist with zero buybacks—neutral-to-friendly but with reversals. FY2025 declared dividends totaled RMB 532 million (payout ratio 66.1%); 2026 interim dividend of RMB 221.6 million (65.9%), proceeding on schedule even during the trading suspension—for shareholders unable to trade, this is the only cash return; FY2026E full-year DPS approximately HK$0.40, corresponding to a dividend yield of approximately 9.9% at the frozen price (9.6% TTM). On the other hand: zero buybacks since listing; dividend plan reversed twice within one year (approved→cancelled→replaced with a larger special dividend); during the suspension, a share incentive scheme for up to 10% of H shares was adopted (potential dilution ~9%; exercise price must be anchored to the grant-date market price, and options cannot be granted during the suspension). Sustainability constraints are real: distributable reserves were only RMB 483 million at end-2025, while RMB 488 million was already declared in 2026, crossing the line—future dividends depend on replenishment from that year's profits—if net profit attributable falls below ~RMB 500 million, the DPS implied by a 66% payout ratio will shrink accordingly.
Risk signals: The pre-listing dividend of RMB 96.5 million in 2023 was directly offset against receivables from the controlling shareholder (Hengsheng Herui and Wang Xiao'a)—traces of related-party fund flows; in May 2026, the supervisory committee was abolished (its former chairman was affiliated with the actual controller), with duties transferred to the audit committee; Orchid Asia, the only early-stage institutional shareholder, fully exited in 2025. The core issue with management is not competence (supply chain and franchise operations are industry top-tier) but the absence of governance checks and protections for minority shareholders.
The company does not disclose gross margin by segment; the following is a breakdown of revenue structure and business logic:
| Revenue line | FY2025 share | FY2025 YoY | 2026H1 YoY | Business logic in one sentence |
|---|---|---|---|---|
| Sale of goods and equipment (to franchisees + third parties) | 94.9% | +10.1% | +7.0% (goods -2.3% / equipment +450%) | Supply-chain wholesale: ingredients/packaging/equipment sold to 6,038 franchisees; revenue recognized upfront |
| Royalties and franchise fees | 3.6% | -10.2% | -19.5% | Initial fees amortized straight-line over an estimated 5-year franchise term + monthly fees; contraction reflects slowdown in new signings |
| Others (design services/agency operations/direct stores) | 1.5% | +58.3% | +22.0% | Only 13 direct stores, for brand showcase purposes |
The profit engine is the goods and equipment sales line (94.9% of revenue, no segment gross margin disclosed; at a consolidated gross margin of 30–32.5%, it contributes the vast majority of gross profit); the truly structural information lies within the revenue line: the divergence between goods (high stickiness, driven by existing stores' sales) and equipment (one-off, driven by credit policy)—in 2026H1, growth of 100% came from equipment while goods were negative; revenue quality is deteriorating. The amortization of franchise initial fees over a "prescribed 5-year franchise term" relies on subjective estimates; against an 11% closure rate, there is room for overestimating the pace of deferred revenue release (see the "Financial Engineering and Cross-Period Consistency" section).
Accounting red flags: ① Surge in equipment installment receivables (medium-high)—trade receivables +325% to RMB 194 million, turnover days 1.9→8.6, with an 18-month credit period secured by equipment collateral; "revenue recognition ahead of cash return"; ② Franchise initial fees rely on a 5-year estimated amortization period (low)—with an 11% closure rate, the pace of release may be overestimated; ③ Large fluctuations in government grant size (low)—FY2024 at 15.2% of net profit attributable, plunging to RMB 2.748 million in 2026H1; profit is sensitive to grants; ④ Pre-listing dividend offset against shareholder receivables (low)—RMB 96.5 million offset against controlling-shareholder receivables via dividend.
Cross-period consistency: ① OCF/net profit 1.21→0.72→0.83→0.56—the company did not explain the FY2024 halving and attributed 2026H1 to increased receivables; partially consistent with the disclosed direction; ② Active members 59.3→56.3→35.9 million, declining continuously and accelerating—unexplained by the company; ③ Gross margin 34.4%→31.2%→32.5%→30.0%—the period attributions (concessions/cost control/coffee concessions) are consistent with the figures' direction; ④ Contract liabilities RMB 324→219→136→96 million—the "installment collection policy" framing is consistent across periods; ⑤ Store closures 220→890→933→499 (half-year), closure rate rising to ~11% and staying there—unexplained by the company. Overall judgment: no systematic accounting manipulation, but the "concessions + credit expansion" policy mix is pressing down revenue quality and cash conversion; receivables aging and impairments in the 2026 annual report are the next verification point.
Current market data and multiple percentiles: Current price HK$4.035 (frozen anchor as of 2026-10-30; last trade 2026-10-12, suspended from 10-13), market cap HK$5.96 billion. PE(TTM) 6.35x (~1st percentile since listing), static PE (FY2025 net profit attributable) 6.69x, PB 1.33x (lowest since listing, 3-year median 2.95), TTM dividend yield 9.6%. Listed for only 2.5 years and frozen due to suspension, historical percentiles carry limited reference value—this stock's valuation issue is not "percentile level" but "absence of price discovery": net cash of HK$4.13 billion is 69% of market cap; PB is essentially a cash-discount indicator. Earnings contain no cyclical trough or heavy reinvestment distortions, but include ~18% non-recurring items; ex-items recurring PE is approximately 7.3x.
| Peer | Market cap (HK$ hundred million) | PE(TTM) | 2026H1 revenue growth | 2026H1 net profit growth | Store count |
|---|---|---|---|---|---|
| Mixue Group | 64.8B | 10.26 | +2.3% | -14.7% | ~59,800 |
| Guming | 51.8B | 14.72 | +31.9% | -3.4% (adjusted +44.4%) | 13,554 |
| Auntea Jenny | 5.99B | 8.40 | +42.4% | +58.3% | 13,155 |
| Chagee (US) | — | N/A | +2.5%~3.5% | — | 7,453 |
| Nayuki | ~1.5B | Loss-making | -13.1% | Loss (-RMB 97 million) | 1,685 |
| ChaPanda | 5.96B | 6.35 | +6.2% | +3.2% | 8,863 |
Market-implied expectations: Back-solving at the current price—EV of RMB 1.557 billion ÷ (11%–13% cost of equity, zero-growth perpetuity) implies sustainable FCFE of only RMB 170–200 million/year, about 28% of FY2025 FCF (RMB 656 million), equivalent to the market assuming recurring earnings permanently fall to ~RMB 240 million from the actual 650–700 million. In one sentence: the current price requires the company to cut recurring earnings to one-third of reality, or requires that roughly 70% of the RMB 3.5 billion in cash is ultimately unreachable. The timing limitation of this pricing must be stated—the frozen price formed before the allegations were made public; the "implied expectations" above are actually the pre-suspension market pricing of "stalled share + per-store pressure," and do not (and cannot) include information from the suspension event itself.
Three-layer value (EPV): Asset value (floor) = net cash HK$2.79/share (HK$2.66 excluding FVOCI equity); zero-growth EPV = sustainable FCFE of ~RMB 500 million (HK$0.399/share, normalized at 75–80% cash conversion of recurring profit, excluding non-operating cash income, accounting for working capital absorbed by equipment receivables) ÷ 12% cost of equity + net cash = ~HK$6.12/share (range 5.56–6.78). Current price 4.035 = cash layer 2.79 (69%) + operating residual 1.24 (31%); the operating residual is only ~38% of the operating portion of zero-growth EPV (~HK$3.32)—the market has marked down the zero-growth operating value itself by 40%, and the implied price paid for the coffee/overseas growth option is negative (current price below EPV; the residual is a discount, not a growth premium). Note on the three layers' relationship: the current price is mainly supported by the asset layer; if trading resumes and cash reachability is confirmed, the value anchor will first repair toward EPV (6.12); if the restitution process reaches company assets, the asset layer itself shrinks (approx. HK$2.18/share under the Hontex mechanism), and the floor moves down.
Three scenarios and odds (post-resumption value distribution, HK$/share):
Probability-weighted fair value ~HK$5.63 (approx. +39% vs. current); the current price sits between the bear and base cases, clearly toward the lower end of the distribution—odds are skewed positive but the distribution is extremely wide (bear -44%/bull +126%), and realization strictly requires resumption—the odds are untradable during the suspension, and time costs (liquidity discount, dividend opportunity) are a certain loss.
Own earnings forecast (reconciliation anchor): FY2026E revenue RMB 5.40–5.55 billion (+1%~+3%), net profit attributable RMB 730–790 million (H2 implies -5%~-18%, of which equipment revenue RMB 560–630 million, goods RMB 4.53–4.60 billion, franchise fees -12%~-18%); FY2027E revenue RMB 5.30–5.60 billion (-2%~+1%), net profit attributable RMB 680–760 million (equipment base declining vs. overseas/coffee increments). This is 8%–13% below pre-suspension sell-side estimates (CICC RMB 836 million, Guotai Junan RMB 845 million); the divergence lies in the slope of per-store weakness and the drag from equipment gross margin; no management quantitative guidance to compare against. Methodology: extrapolated from realized 2026H1 figures, assuming per-store goods sales -4%~-6%, stores +2%~+3%, gross margin 29.5%–30.5%.
Conclusion: Undervalued, with quality and price stated separately. Quality is mediocre-to-weak—losing share in a price war over the installed base, per-store pressure, deteriorating revenue quality; but the price already embeds substantial bad news, with +29% upside to the base-case fair-value lower bound and a margin of safety of +28.9%. Execution note: the stock cannot be traded during the suspension, and the first post-resumption day's price may deviate sharply from the frozen anchor (in both directions); this rating is essentially an event-driven judgment of "positive expected value of the post-resumption distribution + positive probability-weighted odds," suitable for capital that can tolerate 12–18 months of illiquidity and small position sizing; before resumption, the most effective verification tools are dividend receipt and investigation milestones, not the price.
Market Size: China's freshly-made tea beverage market generated GMV of approximately RMB 258.5 billion in 2023 (CIC estimate, half of total fresh beverage GMV of RMB 517.5 billion), with a 2018–2023 CAGR of about 19%—but the high-growth phase has passed: per Hongcan big-data estimates, market size in 2025 was RMB 187.0 billion with growth slowing to +6.4%; iiMedia Research's broader estimate for 2024 was RMB 354.7 billion (+6.4%). There is a clear gap between institutional forecasts (CIC 2024–2028 CAGR of 16.4%, with the main incremental battleground in tier-3 and lower-tier cities, projected to grow from RMB 96.0 billion in 2023 to RMB 268.2 billion by 2028) and realized single-digit growth rates—forecasts carry downward-revision risk. Headline industry figures should use association/top-tier institutional estimates, with aggregator data used only for cross-reference. Per-capita annual consumption of 11 cups (2023, CIC) versus 50+ cups in Hong Kong/Taiwan leaves a penetration narrative intact, but store networks are already over-dense; further penetration gains can now only come from per-store frequency, not store openings.
Value Chain and Value Distribution: Upstream supply of tea leaves/fresh fruit/dairy/packaging is ample, and leading brands' bargaining power continues to strengthen via centralized procurement plus in-house production (Mixue produces 100% of core ingredients in-house, with milk powder/lemon procurement costs 10%/20%+ below industry; ChaPanda has its own tea factory with 5,000-ton annual capacity plus packaging plants and 26 warehousing and distribution centers). Midstream brands are essentially "supply-chain wholesalers": they do not profit from retail markups, but from supply-chain spreads on ingredients/equipment/packaging sold to franchisees—sales and services to franchisees exceeded 98% of ChaPanda's 2025 revenue, versus 97.6% for Mixue and over 96% for Auntea Jenny; the industry is structurally homogeneous. Gross profit is retained mainly in the midstream: brand gross margins run 30–33%, while franchisee store-level gross margins are only about 14% (industry review estimates)—downstream franchisees bear store investment (ChaPanda from about RMB 220,000 upfront, Mixue RMB 210,000–270,000, Bawang Chaji RMB 500,000+) plus rent and labor; payback periods have stretched from the 5.5 months touted during the industry's golden era to 18–24 months (28+ months in core commercial districts, Lansha Consumer 2026; ChaPanda franchisee payback stretched to 2–6 years per industry reviews). ChaPanda sits in the midstream brand layer: strong bargaining power upstream, moderately weak bargaining power downstream over franchisees—the two rounds of price cuts and concessions since 2024, plus 18-month installment credit for coffee equipment, all represent profit and credit transferring from headquarters to store level.
Supply-Demand and Competitive Structure: Supply is severely overbuilt and consolidation is underway—per Zhaimen Canyan, 102,000 stores opened and 131,000 closed from Dec 2024 to Dec 2025, a net decrease of 29,300 (year-end total ~393,200); in 2026H1 the stock was ~383,100, a net one-year decline of 43,200, with a closure rate of 16.2%; 71% of tea brands have halted expansion (Economic Daily, 2026-08). Concentration is accelerating: retail sales CR5 rose from 38.5% in 2020 to 46.8% in 2023 (CIC). By price band: in the budget band (<RMB 10), Mixue alone accounts for ~60% of merchandise sales (oligopoly); in the mass band (RMB 10–20, where ChaPanda sits), CR3 is ~43%—Guming 18%, ChaPanda 16%, Auntea Jenny 9% (2023 merchandise sales, CIC); in the premium band, Bawang Chaji ranks first at 20.3% by store count. Competitive intensity: "three stores within 100 meters" of the same brand is common; RMB 9.9/RMB 5 price wars were ignited by delivery platforms (nearly RMB 100 billion burned in 2025); the 2026 "Rules on Internet Platform Pricing Behavior" banning forced price cuts by platforms makes subsidy phase-downs certain. Substitution threat: freshly-ground coffee (Luckin at RMB 9.9/Cotti at RMB 4–8) is the biggest cross-category substitute, and tea brands are counterattacking via tea-coffee integration—Guming's coffee machines cover 94% of stores with coffee exceeding 20% of revenue; ChaPanda covers 2,700+ stores with cup volume share exceeding 10%. Entry barriers: low at the single-store level (RMB 200,000–300,000), high at scale (supply-chain-heavy assets + franchise management at the ten-thousand-store level + franchisee trust)—the latter is precisely why tail players are being squeezed out.
Cycle and Regulation: The industry is in the early stage of maturity with sentiment declining and bottoming—in 2026H1, six listed tea companies posted combined revenue of +9% but combined net profit of -2.7% (confirming an inflection of revenue growth without profit); after the "IPO debut year" of 2025 (Mixue/Guming/Auntea Jenny/Bawang Chaji), sector-wide valuations compressed in 2026 (the four companies' market caps at one point shed over RMB 70 billion within the year). Leading indicators: Zhaimen Canyan monthly store openings/closures and industry closure rates, top-brand single-store GMV/same-store (Bawang Chaji same-store GMV down for seven consecutive quarters, -16.1% in 2026Q2), delivery subsidy intensity, franchisee closure rates and new signings. Regulatory direction: full-chain food safety oversight (2025 State Council General Offices' opinion + SAMR series of regulations + 2026 industry association group standards) raises compliance costs, favoring leaders; delivery "anti-involution" pricing rules ease predatory subsidies; franchise filing is standard practice. Industry regulation itself is neutral-to-positive for leaders—but ChaPanda's own SFC trading suspension is a company-specific major regulatory event, layered on top of industry headwinds.
Company Positioning Within the Industry: A niche incumbent with declining relative share. In 2023, retail sales market share was 6.8%, ranking third industry-wide (Frost & Sullivan), and ~16% in the mass band, ranking second (CIC); but in 2025 stores grew by only 226 net, significantly trailing Guming (+3,640), Auntea Jenny (+2,273), and Mixue (+13,000)—the weakest expansion momentum among the six listed tea companies. Divergent metrics must be presented side by side: company-level disclosures claim industry leadership, while third-party estimates (CIC/Frost & Sullivan) show a downward share trend; the difference stems from methodology (retail sales vs. store count vs. cup volume) and year. Moat sources: supply chain (one of the few brands able to distribute short-shelf-life fresh milk and fresh fruit nationwide at high frequency) + franchise network relationships (sustained by concessions and installment policies) + overseas first-mover advantage (a Korea sample that is profitable overall). Single-store average daily retail sales fell from RMB 7,414 in 2021 to RMB 6,887 in 2023, with 2024H1 per-store revenue down -26% YoY (prospectus and historical disclosures); no longer disclosed post-IPO—the opacity of the single-store model is itself a signal of positional weakness.
The valuation anchor of the franchise model lies not in the brand's financial statements but in franchisee single-store returns—if franchisees cannot make money, the brand's "supply-chain wholesale" revenue is water without a source. This section assembles a picture of ChaPanda's single-store economics from available metrics:
Full Sequence of Openings and Closures: Mainland franchised store openings 1,663 (FY2023) → 1,477 (FY2024) → 1,159 (FY2025) → 669 (2026H1, still up vs. 466 in 2025H1); closures 220 → 890 → 933 → 499 (annualized ~1,000 per half-year), with the closure rate rising from 2.8% to ~11% and holding; total stores 7,801 → 8,409 → 8,659 → 8,863 (mainland 8,791 + overseas 72). High levels on both openings and closures mean the network has entered a "high-turnover, blood-transfusion" state—the net adds (only +226 in FY2025) mask massive two-way churn.
Franchisee Structure: 6,038 franchisees (net +115 in 2026H1), with the top five customers at only 0.21%—extremely dispersed, with no large-customer dependence, but also meaning the brand has limited bargaining and disciplinary power over any individual franchisee's operating distress; of the 1,218 terminations in FY2025, 735 were store transfers (new operator, same store), 460 exited for their own reasons, and 23 were terminated by the company.
Available Readings on the Single-Store Model: The company stopped disclosing single-store GMV/same-store/payback after listing, leaving only the qualitative statement that "single-store sales performance remains stable." Assemblable proxy indicators: ① Goods revenue / average store count as a proxy for per-store shipments—2026H1 goods revenue of RMB 2.257 billion / ~8,762 average stores ≈ RMB 258,000 per-store half-year shipments, roughly -5% to -6% YoY (corroborating Guotai Haitong's estimate of -5.5% per-store goods sales); ② Contract liabilities (franchisee prepayments) fell three straight times from RMB 324 million → 96 million—a leading indicator of new franchise intent and willingness to prepay; ③ Active members of 35.9 million (-36.2%)—the traffic pool for end-market sales is shrinking; ④ Industry side: single-store investment from ~RMB 220,000, payback of 2–6 years per industry reviews, industry closure rate 16.2%—the median return for franchisees as "customers" has most likely fallen below their opportunity cost of capital, which is precisely the macro backdrop for the company sustaining its network via margin concessions (gross margin -2.6pp) plus 18-month equipment installments (credit extension).
Store-Opening Ceiling: Donghai Securities estimates an upper bound of ~489,900 freshly-made tea stores on the mainland vs. a current stock of 383,100—headroom exists but is structurally mismatched (oversupply concentrated in the low-price band and high-density commercial districts). ChaPanda's 4,099 tier-3 and below stores (+7.2%) are one of its few segments growing faster than the whole; going down-market is its remaining penetration avenue, but the down-market band is precisely Mixue's heartland (60% share in the budget band). The 72 overseas stores in 13 countries (130+ signed, one store every 3 days) are a genuine incremental option, but the base is under 1% of the total.
Peer Single-Store and Expansion Comparison: Bawang Chaji's average monthly single-store GMV fell from RMB 512,000 in 2024 to RMB 338,300 in 2026Q2 (-16.3%)—even the industry's strongest single-store economics are rapidly regressing to the mean; Guming sustains its stores through regional densification (2,000+ stores in Zhejiang) + cold-chain delivery every two days, with a net +3,640 stores—the best in its band; Auntea Jenny grew by a net +2,273 via a multi-brand matrix, with its closure rate falling from 6.8% to 4.2%. ChaPada is not industry-best on any of "single-store strength, expansion speed, closure control," but the gaps lie mainly on the growth side rather than the survival side.
Overall Assessment: Cautiously bullish, confidence 0.50, horizon 12–18 months. The structure of the judgment: quality (a niche incumbent with a solid supply chain, but declining share and single-store economics) × price (net cash at 69% of market cap, EV at 2.4x recurring earnings, lowest percentile since listing) × catalyst (a binary resumption path, with the 18-month deadline forcing convergence). Reasons confidence is held at 0.50: the base-case fair value deviates from the current price by ~47% (historical directional hit rate in the >30% zone only ~50%), resumption timing and outcome are inherently unpredictable, and the suspension distorts the price anchor. Strategic implication: not actionable before resumption; after resumption, if the clearing price is significantly below the lower bound of the base range (HK$5.2) and the regulatory outcome has not deteriorated, the risk-reward further improves; if regulation confirms company-level responsibility, the "deep value" narrative should be abandoned at any price—the cash floor and dividend logic fail simultaneously.
Key Monitoring Points: Whether the 2026-11-30 interim dividend of HK$0.175226/share arrives in full (the most direct verification of cash accessibility); whether the HKEX resumption guidance letter is received before mid-January 2027; establishment and findings of the Independent Investigation Committee (note: as of this report's date, only media reports, no company announcement); regulatory pace for co-case listed companies Kangjiyun/Yinjian International (timing anchor); FY2026 annual report in March 2027 (closure counts, contract liabilities, gross margin, receivables aging, final dividend proposal); the 18-month delisting deadline of 2028-04-13.
Risk and Catalyst Summary (Written Record): Upside: the Independent Investigation Committee clarifies responsibility, resumption guidance lands, dividends paid on time and continued, controlling shareholder increases stake after resumption, H-share incentives anchored to post-resumption market price and tied to performance, and a low-probability premium privatization offer. Downside: the listed company named as a subject of investigation, IPO proceeds confirmed as moved away via undisclosed agreements, fines/restitution eroding cash, suspension exceeding 12 months entrenching a liquidity discount, the 2026 annual report confirming accelerating closures and gross margin breaking below 29%, impairment of coffee equipment receivables, and a lowball privatization squeezing minorities. Material progress on any of the above will trigger an update of this report and a re-examination of its theses.